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A b s t r a c t
Background: Cardiovascular diseases (CVD) have been the main cause of death in Poland for the last five decades. In 2010, 
CVD caused 46.0% of all deaths in Poland. An analysis performed using the IMPACT model, have shown that the reduction 
in mortality due to ischaemic heart disease, which took place in Poland, was primarily a result of lifestyle changes and of 
changes affecting risk factors in the population of adults. From the perspective of health policy planning it is very important 
to know the prevalence of CVD risk factors and to be aware of trends in the population.
Aim: The NATPOL 2011 Survey was a cross-sectional observational study aimed to assess the prevalence and control of CVD 
risk factors in Poland. The aim of this paper is to describe the objectives and methodology of the NATPOL 2011 project.
Methods: The survey was designed as a representative observational study and was carried out on a representative sample of 
Polish residents aged 18–79 years. The planned size of the research sample was 2,400 subjects. Participants were randomly 
selected in bundles, in a stratified, proportional draw performed in three stages. The study was composed of a questionnaire 
interview, blood pressure and anthropometric measurements as well as a blood and urine sample collection. The examination 
consisted of two visits at subjects’ homes and was performed by well-trained nurses.
Results and conclusions: Letters of invitation were sent to 4,420 potential participants. Of those, 786 persons could not 
be contacted because the addresses were wrong, the respondents resided at an address other than their registered place of 
residence or, in some cases, the respondents died prior to the survey. Among 3,634 addresses of the persons sampled for the 
study there were 661 (M: 328, F: 333) “closed doors” (the nurse was unable to contact the respondent during three consecu-
tive attempts) and 560 (M: 295, F: 265) direct refusals. Finally, 2,413 subjects participated in the study and 2,401 of them 
completed all the procedures in the survey. The data mentioned above give the response rate of 66.4%.The structure of the 
study sample, including age groups and gender is almost identical to the structure of the adult population of Poland in 2010, 
according to the Central Statistical Office data. The sample reflected the structure of the adult population quite well, therefore 
the weights’ adjustments calculated for epidemiological analyses were in range from 0.36 to 4.11. 
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INTRODUCTION
Cardiovascular diseases (CVD) have been the main cause 
of death in Poland for the last five decades. In 2010, CVD 
caused 46.0% of all deaths in Poland (40.8% in males [M], 
and 51.8% in females [F]) [1]. CVD are also the leading cause 
of premature mortality — in 2010 they were responsible for 
26.9% of all deaths in people aged below 65 years [1]. Almost 
a quarter (23.8%) of all disability cases (occurring for the first 
time in life), where the subject is unable to continue their 
professional activity and stay in a job, can be attributed to 
CVD [2]. These facts constitute a substantial medical, social 
and economic burden. 
Since 1991, cardiovascular mortality in Poland has been 
steadily decreasing [3]. Several Central-Eastern European [CEE] 
countries which experienced equally dramatic political changes 
and socioeconomic transformation in the early 1990s, including 
the Czech Republic, Hungary, and Romania, have presented 
similar trends [4]. However, despite these changes, CVD mortal-
ity rates in Poland and other CEE countries after transformation 
still remain much higher than the EU average [4]. 
Residents of Poland live 3–7 years less than citizens of 
the ‘old’ EU countries. The decisive factor contributing to this 
outcome is the fact that CVD-related mortality rates among 
Polish men and women are higher than those in the majority 
of other countries of the European Union (Fig. 1A, B) [5, 6].
An analysis performed using the epidemiological IMPACT 
model, and data from cross-sectional surveys conducted 
between 1991 and 2005, have shown that the reduction in 
mortality due to ischaemic heart disease which took place 
over that period was primarily the result of lifestyle changes 
and of changes affecting risk factors in the population of adults 
in Poland (54% of the observed reduction in mortality) [7]. 
Developments in the field of restorative medicine (specifically 
cardiac treatments) also significantly contributed to reducing 
the number of deaths, but to a smaller extent (37%) [7]. 
Hence, it is essential that government health policy plan-
ners monitor the prevalence of lifestyle-dependent CVD risk 
factors. Even more importantly, they should be aware of trends 
regarding the prevalence of CVD risk factors in the population. 
This would allow them to anticipate future changes in mor-
tality, and evaluate the benefits of various population-based 
prevention strategies concerning CVD, targeting high-risk 
factors and groups.
The most recent large-scale cross-sectional studies of 
prevalence and control of CVD risk factors in the general 
adult population in Poland were carried out in 2002 (NATPOL 
2002) [8, 9] and between 2004 and 2007 (WOBASZ) [10]. 
It has been established that the intervals between surveys 
should not be excessively long, since it has been shown that, 
after effective population-scale interventions, changes may 
occur much faster than had been believed until now (i.e. even 
after a period as short as several months [11]). Thus, it was 
imperative to schedule a new study to be carried out in 2011. 
The NATPOL 2011 Survey sought to describe the preva-
lence and control of CVD risk factors in a representative sam-
ple of adults. The aim of this paper is to describe the objectives 
of the NATPOL project, as well as the recruitment procedure 
and the characteristics of the study group, the methodology 
of research and the study flow.
Research objectives  
and main survey characteristics
The NATPOL 2011 Survey was a cross-sectional observational 
study aimed to assess the prevalence and control of CVD risk 
factors in Poland, based on a representative sample of adults 
aged 18–79. The survey was carried out between January 
and August 2011. The main aim of the survey was to assess 
the prevalence and control of arterial hypertension, sedentary 
lifestyle, smoking, lipid disorders, metabolic syndrome, obesity 
and diabetes, as well as other factors related to CVD risk such 
as chronic kidney disease, sleeping disorders, depression and 
selected psychosocial factors. We also wanted to determine 
changes in those risk factors in the adult population in Poland 
between the 2002 (the NATPOL 2002 Survey) [8, 9] and 
2011 (the NATPOL 2011 Survey).
The study was composed of a questionnaire, blood 
pressure (BP) and anthropometric measurements as well as 
a blood and urine sample collection. The examination con-
sisted of two visits to subjects’ homes and was performed by 
trained nurses. The questionnaire was completed during the 
first visit, while the Beck Depression Inventory was given to 
the subject to be self-completed, and was collected at the 
second visit. BP readings were taken three times during the 
first and the second visit. Blood and urine samples were taken 
from subjects at the second visit, after 10 to 12-hour fasting. 
Institutional partners and scientific board
The fieldwork was subcontracted to a company specialising in 
market research projects for the private and public sectors. The 
transportation of biological material to the Central Laboratory 
was subcontracted to a firm with expertise in blood sample 
transport over long distances. Interviewers were recruited 
from among professionally active nurses. Most of them were 
social nurses working within local communities. All nurses 
participating in the survey completed special training prepared 
for fieldwork executors of the NATPOL 2011 Survey.
The key parties responsible for project design and proto-
col were experts from the Department of Arterial Hyperten-
sion and Diabetology of the Medical University in Gdansk 
and, for the implementation and execution, a team from the 
University Clinical Centre of the Medical University in Gdansk. 
The main institutional partners that co-operated in preparing 
the protocol and implementation of the project were: De-
partment of Internal Diseases, Hypertension and Angiology, 
Medical University of Warsaw, Medical College of the Jagiel-
lonian University in Krakow, Department of Epidemiology, 
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B
Figure 1. A. Contribution (number of years) of higher mortality to main causes of death among Polish men in shortening their 
life expectancy compared to men in some other countries, 2010 or latest available year [5]; B. Contribution (number of years) of 
higher mortality to main causes of death among Polish women in shortening their life expectancy compared to women in some 
other countries, 2010 or latest available year [5]; CVD — cardiovascular diseases
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Cardiovascular Disease Prevention and Health Promotion of 
the Institute of Cardiology in Warsaw, Centre of Monitoring 
and Analyses of Population Health of the National Institute 
of Public Health — National Institute of Hygiene in Warsaw, 
and School of Public Health, Statistics and Consulting Unit 
at Boston University.
The Scientific Board developed the study protocol and 
the application to the Ethical Committee, elaborated survey 
questionnaires, selected blood and urine tests, and established 
and approved laboratory methods, prepared instructions for 
nurse trainers, monitored the study flow, controlled the work 
of the Central Laboratory, and the preparation of the central 
database. 
METHODS
Recruitment of subjects and the research sample
The survey was designed as a representative observational 
study and was carried out on a representative sample of Polish 
residents aged 18–79 years. The planned size of the research 
sample was 2,400 subjects. Research participants were 
randomly recruited in bundles, in a stratified, proportional 
draw performed in three stages. The first stage draw identi-
fied local administrative units: urban, rural and urban-rural 
municipalities. Figure 2 shows the distribution of 248 mu-
nicipalities randomly drawn in the NATPOL 2011 Survey. 
During the second stage, streets in urban municipalities and 
villages in rural municipalities were drawn. The third stage 
of the draw enabled the random identification of individuals 
in bundles and was executed using the national PESEL da-
tabase (Polish Universal Electronic System for Registration of 
the Population) maintained by the Ministry of Internal Affairs 
and Administration.
The first stage draw identified local administrative units, 
including urban, rural, and urban-rural municipalities (gmina). 
It was a stratified proportional draw. Geographical strata were 
created on the basis of 16 provinces (województwo) within 
which there were four location type classes (16 provinces 
times four location type class, minus exceptions = 61). Loca-
tion type classes were defined as follows: village/countryside; 
town with population up to 50,000; town/city with population 
from 50,001 to 200,000; city with population over 200,000.
The number of residents aged 18 years and over was 
determined for each stratum. The number of interviews to be 
conducted in each stratum was determined so as to ensure 
that it was proportional to the number of adult residents in 
the relevant stratum and that the total interview count was 
kept at 2,400. The number of geographical bundles drawn 
was determined to be w = round (n/s) = 218, where n means 
the planned total number of interviews and s the average 
number of interviews in a bundle (11). The sampling interval 
was calculated by dividing the size of the population aged 
18 to 79 (29,605,773) by the number of bundles and round-
ing the result to the nearest integer. The  resulting number 
was I = 135,806. All the municipalities where population 
size exceeds the value of I (in total: 22 urban municipalities) 
were automatically included in the sample. The number of 
interviews in these municipalities was determined proportion-
ally to the number of adult residents of these municipalities 
relative to the number of all adult residents of Poland. The 
remaining municipalities were sorted according to province, 
location type class and a pseudorandom variable with a uni-
form distribution. The RAND (‘UNIFORM’) function of the SAS 
software was used. The number of interviews for each stratum 
was set to be proportional to the size of the population in 
the stratum. The sampling interval was separately determined 
for each stratum, in a way similar to the method described 
above. The municipalities to be included in the sample were 
selected according to the interval thus derived. The number 
of interviews in each municipality was determined so as to 
obtain within the stratum a similar number of interviews per 
municipality, and to obtain the sum total for the stratum equal 
to the number of interviews to be completed in that stratum. 
The number of respondents obtained in each stratum was 
proportional to the number of adult residents in the stratum.
The second stage of sample selection involved a ran-
dom draw of bundles in municipalities i.e. streets in urban 
municipalities and villages in rural municipalities. In cases of 
mixed urban-rural municipalities, streets and villages were 
drawn, respectively. These bundles were drawn within the 
municipalities selected during the first phase of the sampling 
process. The sampling frame for the third stage of sample se-
lection was the list of individuals aged 18–79 who live in the 
Figure 2. Distribution of municipalities (gmina) randomly 
drawn in the NATPOL 2011 Survey; Legend:  Village;  
 Town ≤ 50,000 reidents (age 0+);  Town 50,001–200,000 
residents (age 0+);  City > 200,000 residents (age 0+)
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selected bundles, registered in the PESEL database. Separately 
in each geographical stratum, individuals were drawn in the 
numbers proportional to the number of residents in each one 
of the 12 demographic categories. These categories were de-
fined on the basis of gender and age (i.e. male/female; six age 
categories: 18–24, 25–34, 35–44, 45–54, 55–64 and 65–79). 
Because of the expected response rate, it was planned 
to draw a sample five times as large as the actual number of 
interviews planned. The sample thus drawn was divided into 
the base set of 2,400 addresses and supplementary sets. Sup-
plementary address sets were used only when all the addresses 
in the base set were used up without reaching the target 
quantity of interviews (e.g. in the event of refusals or if contact 
with the respondent at the base address was not possible).
Description of an individual subject’s examination
The examination of an individual subject comprised the 
following components: (1) Completing the questionnaire; 
(2) Taking BP readings and anthropometric measurements; 
(3) Collecting blood and urine samples.
The survey fieldwork was carried out by 234 nurses 
who lived in or close to the randomly selected geographical 
bundles. The nurses were recruited and specifically trained 
for the study by the authors of the project. Prior to fieldwork, 
letters were sent to all the individuals selected in the random 
sampling procedure, providing information on the activities 
planned under the project, the project objectives and the 
implementation procedure. The project involved two visits 
by a nurse to the subject’s home.
During the first visit the nurse:
1. briefly presented to the subject the objectives of the 
programme,
2. confirmed the subject’s personal data and obtained 
written consent concerning participation in the survey,
3. completed the questionnaire, 
4. performed a series of BP measurements — three BP 
measurements on the right arm, 
5. took anthropometric measurements,
6. arranged the date and time of the next visit with the 
subject, providing information that blood samples would 
have to be taken after 10–12 hours of fasting and leaving 
the subject a container for a urine sample, 
7. instructed the subject how to complete the Beck Depres-
sion Inventory before the second visit.
During the second visit, the nurse:
1. performed a second series of BP measurements, 
2. took samples of venous blood from the patient, making 
sure that the patient had not taken any food or liquids of 
any calorific value in the previous 10 to 12 hours, 
3. transferred the sample of urine from the container to 
a vacuum transport tube, 
4. filled out the referral form to the lab and transported 
the blood and urine samples to the local laboratory 
designated by the co-ordinator of the study, within up to 
two hours after blood collection,
5. examined the score of the depression questionnaire. 
In the cases of respondents who had suicidal thoughts 
(question D9) and had been tested to receive ≥ 17 points, 
or had a severe set of depressive symptoms (received 
> 21 points), the nurse had to forward this information 
promptly to the co-ordinator of the study who contacted 
the patient and his or her family doctor.
Study questionnaire
The questionnaire consisted of six introductory, administrative 
questions or items (demographic data), 64 closed questions, 
eight open questions, five questions concerning education, 
marital status and employment, as well as five items to be 
filled in with the results of BP and anthropometric measure-
ments. The standardised Beck Depression Inventory consisted 
of 21 questions. The English version of the main questionnaire 
and the Beck Depression Inventory are available online at: 
http://natpol.eu/files/NATPOL2011_questionnaire_eng-
lish_translation.pdf
The medical part of the questionnaire included detailed 
questions about present clinical symptoms and diseases, medi-
cations taken by the subject, awareness of CVD risk factors, 
past medical history including details of all hospitalisations 
and family medical history in first degree relatives. Moreover, 
questions were asked concerning smoking, leisure time and 
occupational physical activity, sleep-related problems and 
sleep apnoea. 
A separate section of the interview was dedicated to 
the respondent’s knowledge about methods of CVD preven-
tion and complications due to poor control of risk factors; 
the sources of knowledge about health and disease and the 
intentional usage of any preventive methods. 
The final part of the questionnaire included questions 
concerning education, marital and professional status, as 
well as economic status and barriers concerning access to 
medical services.
Blood pressure and anthropometric measurements
During the visits to the subject’s home, the nurse took a series 
of BP readings (three during each visit). Each measurement 
was performed with the participant in a seated position, on 
the right upper arm, after at least 5 min of rest and at 1 min 
intervals. The patient was not allowed to smoke cigarettes, 
drink coffee or do physical exercise in the 30 min before 
the BP readings. The results were recorded in the medical 
questionnaire and on a special form given by the nurse to 
the subject at the conclusion of the visit with an interpreta-
tion of the results obtained. During the second visit, the BP 
measurements were performed before collecting the blood 
samples. BP readings were taken using fully automatic oscil-
lometric BP measuring devices (A&D UA 767), certified by the 
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Association for the Advancement of Medical Instrumentation 
[12], the British Hypertension Society and the European So-
ciety of Hypertension [13]. Before the first measurement, the 
nurse measured the circumference of the patient’s right arm. 
If the patient’s arm circumference was ≥ 32 cm, the readings 
were performed using a wider cuff. The nurse recorded the 
pulse rate and BP values with an accuracy of 1 mm Hg.
Anthropometric measurements included:
 — weight — weighing the patient with his/her shoes off and 
dressed in light clothes (without outer garments — jackets, 
coats, etc.), using approved personal electronic scales, 
with accuracy to the nearest 0.1 kg, 
 — height — using a portable personal measuring device, 
with accuracy to the nearest centimetre, 
 — waist, hip, and neck circumference — using a tailor’s 
tape measure, with an accuracy to the nearest 0.5 cm.
Collecting blood and urine samples
Blood samples were collected at the patient’s home. The 
biological material was taken from the subject 10 to 12 hours 
after the last intake of food or fluid of any calorific value. The 
nurses visited the patient with a pre-assembled sampling kit. 
Venous blood sample of 28 mL was collected from re-
spondents in a sitting position using a vacuum tube system. 
After taking a sample of venous blood and transferring urine 
into a vacuum transport tube, the nurse transferred the sam-
ples to a local laboratory to obtain serum/plasma samples 
within up to two hours after blood collection.
Local laboratories were used in the study because they 
were located close to the geographical municipalities/bundles 
selected for the project. The task of the local laboratories was 
to perform the preliminary processing of biological material 
and to ensure its secure preservation i.e. to separate se-
rum/plasma samples by centrifugation, to freeze the obtained 
plasma, serum and urine samples at –20°C and to store them 
at –20°C before transferring them to the Central Laboratory 
in Gdansk. Then the local laboratory prepared and released 
the material for transport to the Central Laboratory.
Transport of the frozen material  
and testing in the Central Laboratory
Within no more than six weeks, the biological material was 
transported to the Central Laboratory (Central Clinical Labo-
ratory of the University Clinical Centre of the Medical Uni-
versity in Gdansk), where the blood and urine analyses were 
performed. The biological material was transported frozen, 
in containers with dry ice, by a courier company specialising 
in the transportation of blood samples. 
After transporting the material to the Central Laboratory, 
one tube of frozen serum, as well as the plasma and urine 
samples, were thawed to perform the laboratory tests. The 
list of blood and urine tests performed and methodology 
are presented in Table 1 and Supplement 1. The results of 
routine biochemical laboratory tests were sent back to the 
participants. In the case of out-of-reference values, a special 
commentary and a letter advising the subject to consult a pri-
mary care physician was attached. The subjects with fasting 
glucose of 100–125 mg/dL or ≥ 126 mg/dL were additionally 
referred for a fasting plasma glucose test in a local laboratory.
Ethical and legal issues
The NATPOL 2011 Survey was approved by the Bioethics 
Commission of the Medical University in Gdansk. The ap-
proval concerned the questionnaire and all the procedures 
and measurements, including blood and urine tests and the 
storage of biological material for further scientific research. 
Before enrollment in the study, each participant signed an in-
formed consent form. Each respondent was assigned a unique 
identification number to ensure confidentiality of personal 
data collected during the survey. All questionnaires and all 
Table 1. Laboratory tests in the NATPOL 2011 Survey
Analysis Name of analyser
1. Routine blood tests: 
fasting glucose in blood plasma 
total cholesterol, HDL-cholesterol, LDL-cholesterol (calculated)  
and fasting triglycerides in serum 
sodium and potassium, creatinine, C-reactive protein, bilirubin, albu-
min, alanine aminotransferase and aspartate aminotransferase in serum 
 
Architect c8000 chemistry analyser, Abbott Laboratories
2. Hormones in blood: 
TSH, fT4, fasting insulin in serum Architect i2000sr, immunochemistry analyser, Abbott Laboratories
3. Additional blood tests: 
apolipoprotein A1, apolipoprotein B in serum
NT-proBNP in plasma
BN II Nephelometer, Siemens Healthcare Diagnostics
Immulite 1000 Immunoassay System, Siemens Healthcare Diagnostics
4. Urine tests: 
albumin, creatinine, sodium and potassium Architect c8000 chemistry analyser, Abbott Laboratories
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blood and urine samples originating from a specific individual 
were coded with the same number. The data was coded 
and anonymously stored in the database. The personal data 
referenced in the database is protected against unauthorised 
access with a special password by the study co-ordinator for 
statistics and use of the database.
Statistical issues
The statistical analysis of the data was performed using SAS 
software for Windows (ver. 9.1.3) and R (The R Foundation). 
Basic statistical analyses involving estimation of the indicators 
defined in the study objectives were conducted using the 
procedures of SURVEYFREQ and SURVEYMEANS of the SAS 
package, taking into account the design effect of the survey.
RESULTS
Flow of the study and response rate
Letters of invitation were sent to 4,420 potential partici-
pants. Of those, we found in 786 cases that they were not 
eligible for the study because the participant’s addresses were 
incorrect, or the respondents resided at an address other than 
their registered place of residence, or, in some cases, the 
selected respondents died prior to the survey.
Among 3,634 addresses and participants eligible for the 
study, there were 661 (M 328, F 333) ‘closed doors’ (the 
nurse was unable to contact the respondent during three 
consecutive attempts) and 560 (M 295, F 265) direct refusals.
Finally, 2,413 subjects participated in the study. 2,401 of 
the subjects completed all the procedures in the survey (i.e. 
the questionnaire interview, BP and anthropometric meas-
urements, blood/urine sample taking), and the remaining 
12 subjects completed all the procedures except for the 
blood/urine sample taking.
The data mentioned above gives a response rate of 66.5% 
(M: 65%, F: 68%) if all eligible respondents drawn from the 
PESEL registry are taken into consideration (Table 2). As ex-
pected, the response rate in villages and towns was higher 
than that obtained in cities. 
Characteristics of the study group
Among the participants, there were 1,168 men and 
1,245 women; 974 were aged 18–39, 849 — 40–59 years 
and 590 — 60–79 years. The mean age in the examined 
sample was 44.9 ± 16.0 in men and 46.7 ± 17.2 in women. 
In 2011, the number of adults aged between 18 and 79 years 
in Poland was 29,733,134.
The structure of the study sample, including age groups 
and gender, is shown in Table 3. It was almost identical to the 
structure of the adult population of Poland in 2010, according 
to the Central Statistical Office (Table 3). The sample reflected 
the structure of the adult population quite well, therefore the 
weights’ adjustments calculated for epidemiological analyses 
were from 0.36 to 4.11. The socio-demographic characte-
ristics of the study group are shown in Table 4.
DISCUSSION
Research into CVD risk factors in Poland:  
historical background
The first research into the epidemiology of arterial hyperten-
sion in Poland was carried out and published in 1929 in ‘Pol-
skie Archiwum Medycyny Wewnętrznej’ by Prof. Januszkiewicz 
[14]. Viewed today, the analyses performed at the time were 
already very modern because they assessed the prevalence 
of hypertensive disease in relation to factors such as social 
class. In the 1950s, research into the epidemiology of arterial 
hypertension was carried out in Katowice and in Wroclaw 
by the teams of Prof. Tochowicz [15] and Prof. Falkiewicz 
[16], respectively. In the 1960s, cross-sectional research into 
the selected populations of adult residents of the towns of 
Plock and Sochaczew was carried out under the direction of 
Prof. Askanas [17, 18]. In 1983–1994, under the direction of 
Prof. Rywik and Prof. Sznajd, two research centres in Poland 
carried out research as part of the international multi-centre 
Table 2. Response rates in the NATPOL 2011 Survey
Males Females All
In the whole study sample 65% 68% 66.5%
According to place of residence:
Village 77% 81% 79%
Town < 50,000 residents 72% 74% 73%
Town 50,001–200,000 residents 60% 67% 64%
City > 200,000 residents 46% 53% 50%
Table 3. Structure of examined sample compared to structure of adult population in Poland in 2010 according to the Main 
Statistical Office in Poland [1]
Age range:  
18–79 years
Males Females All
NATPOL 2011 Poland GUS* NATPOL 2011 Poland GUS* NATPOL 2011 Poland GUS*
18–39 40.8% 45.9% 39.9% 41.7% 40.4% 43.7%
40–59 38.0% 36.1% 32.5% 35.3% 35.2% 35.7%
60–79 21.1% 18.0% 27.6% 23.0% 24.5% 20.6%
*GUS — the Main Statistical Office in Poland — data from 2010
www.kardiologiapolska.pl
Tomasz Zdrojewski et al.
388
WHO-MONICA Project (Monitoring Trends in Cardiovascular 
Diseases) which assessed the prevalence of risk factors and 
monitored trends with regard to changes [19]. 
Thus, as we can see, by the mid-1990s there had been 
valuable local or regional projects investigating risk factors in 
Poland, although insufficient to reflect the epidemiological 
situation on a national scale. In 1997, Zdrojewski et al. [20] 
assessed the prevalence of arterial hypertension in the NAT-
POL 1997 project, using for the first time a representative 
sample of 1,664 adult residents of Poland (aged 18–91). In 
the past decade, the main Polish research centres have car-
ried out four new research projects on a nationwide scale, 
based on the representative method. The NATPOL PLUS 
(NATPOL 2002)project (Nadciśnienie Tętnicze w Polsce 
Plus Zaburzenia Lipi dowe i Cukrzyca) was carried out in 
2002 (n = 3,051, age range: 18–94) [8]. The WOBASZ project 
(Wieloośrodkowe Badanie Zdrowia Ludności) was carried out 
in 2003–2006 on a representative sample of 13,545 adult 
Poles aged 20–74 [10]. Another important research project 
which contributed to our knowledge of the epidemiology of 
arterial hypertension was the POLSENIOR study (Aspekty me-
dyczne, psychologiczne, socjologiczne i ekonomiczne starzenia 
się ludzi w Polsce), carried out in 2007–2011 on a population 
of Polish residents aged over 64 (n = 4,949) [21]. 
Sample selection procedure
The NATPOL 2011 Survey used the representative sampling 
method. This method involves randomly selecting a subset of 
elements from the investigated population, so as to precisely 
reflect the structure of the general population. By measuring 
the attributes in the representative sample obtained in this way, 
researchers can draw conclusions concerning these attributes 
in the general population. Representative sampling allows 
researchers to draw conclusions only with regard to the popula-
tion out of which the specific sample was randomly selected. 
Therefore, generalisations such as taking the conclusions from 
local research and extrapolating these to the national popula-
tion are illegitimate and may lead to errors. This is particularly 
true with regard to CVD risk factors, since cardiovascular 
mortality rates differ significantly between various regions 
of Poland. Conducting research into CVD risk factors based 
on a national sample is much more difficult and expensive 
than carrying out research on a local or regional population. 
A specifically difficult aspect is presented by the requirement 
that biological material must be collected, pre-processed and 
transported from local centres to the central laboratory. 
National samples used in the NATPOL series of research 
were each time obtained using the same multi-stage random 
sampling method. It is, therefore, possible to estimate the pa-
rameters for the whole population of Poland in the years 1997, 
2002 and 2011 and to compare changes in these parameters 
over time. Sample sizes were moderate, compared to other 
epidemiological studies, yet they allowed the researchers to 
obtain an estimation error value close to ± 2%. Most impor-
tantly, thanks to representative random sampling adopted, it 
was possible to estimate the value of that error.
Table 4. Socio-demographic characteristics of the study group
Characteristics Males Females All
N % N % N %
Education
Primary or uncompleted primary 124 10.6% 139 11.2% 263 10.9%
Uncompleted secondary 427 36.6% 266 21.4% 693 28.7%
Secondary or uncompleted higher  421 36.0% 527 42.3% 948 39.3%
Higher 196 16.8% 313 25.1% 509 21.1%
Place of residence
Rural areas 617 52.8% 496 39.8% 1113 46.1%
Town < 50,000 residents 146 12.5% 213 17.1% 359 14.9%
Town 50,000–200,000 residents 201 17.2% 209 16.8% 410 17.0%
City > 200,000 residents 204 17.5% 327 26.3% 531 22.0%
Professional status 
Employed/economic activity 660 56.7% 589 47.4% 1249 51.9%
Farmer 44 3.8% 19 1.5% 63 2.6%
Pensioner 272 23.4% 407 32.8% 679 28.2%
Unemployed with unemployment pay 18 1.5% 11 0.9% 29 1.2%
Unemployed without unemployment pay 64 5.5% 80 6.4% 144 6.0%
Not working/student 106 9.1% 136 11.0% 242 10.1%
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Effectiveness of research fieldwork  
in NATPOL 2011
Despite correct sampling, randomness and representativeness 
may be distorted due to numerous respondent refusals to 
participate. This can happen since non-random differences 
may exist between those who agreed to participate and those 
who did not. Some of these differences may be corrected 
at the analysis stage (e.g. differences concerning age and 
gender), whereas others are impossible to detect (e.g. the 
degree to which someone is interested in their own health). 
Therefore, low effectiveness at the fieldwork stage may cause 
a non-random estimation error which is hard to estimate. In 
the survey described here, the effectiveness rate was 66.5%, 
which must be considered very high when compared to other 
surveys carried out at the time in Poland and elsewhere in 
the world. In the final samples, only older people and female 
respondents were slightly overrepresented, and that was cor-
rected using weights.
Diagnostic algorithms in accordance  
with the criteria used in clinical practice
In the NATPOL study, arterial hypertension was diagnosed 
on the basis of three BP readings taken during each of two 
separate visits. Thanks to this, the arterial hypertension diag-
nostic criteria used in the project remained in compliance with 
Polish and European clinical practice recommendations [13], 
which is an approach infrequently used in epidemiological 
studies. The fieldwork nurses who took the measurements had 
been thoroughly trained, owing to which the standard proce-
dure was adhered to. The devices used to take BP readings 
were appropriately certified (BHS, AAMI). Cuffs used in the 
project were matched in size to the arm circumference of an 
individual subject, which reduced the possibility of overesti-
mating the prevalence of arterial hypertension among obese 
respondents. This may be important, since in 20–30% of peo-
ple in Poland arm circumference equals 32 cm or more and, 
as a result, BP readings taken with the use of a standard-size 
cuff lead to overestimated results [22].
Future directions and analyses:  
how the data will/can be used
Data from NATPOL 2011 Survey will be available to the 
scien tific community for research, as well as to the Ministry of 
Health, the National Health Fund, the Parliamentary Commis-
sion of Health, and to commercial insurance companies. Ex-
tensive use of this data by a large number of investigators and 
institutions will favourably impact public health by providing 
new insights into disease prevention. The data, especially 
when compared to that from the NATPOL 2002 Survey, 
will be very helpful in developing an epidemiological model 
for the prediction of future changes in mortality caused by 
coronary heart disease in Poland. This model with the appli-
cation of IMPACT-Pl (7) would also enable the development 
of alternative action scenarios for the primary and secondary 
prevention for CVD in Poland and cost-effectiveness analysis 
of these scenarios. Such a project, in co-operation with the 
Commission of the European Union (European Heart Health 
Strategy II — EuroHeart II), is currently being conducted by 
the Medical University of Gdansk.
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S t r e s z c z e n i e 
Wstęp: Choroby układu sercowo-naczyniowego (CVD) są główną przyczyną przedwczesnej umieralności w Polsce. Od 1991 r. 
umieralność spowodowana tymi schorzeniami w naszym kraju systematycznie maleje, jednak nadal pozostaje jedną z naj-
większych w Europie. Analiza wykonana z użyciem modelu epidemiologicznego IMPACT i danych pochodzących z badań 
przekrojowych prowadzonych w latach 1991–2005 wykazała, że umieralność spowodowana chorobą niedokrwienną serca 
w ostatnim 20-leciu zmniejszyła się głównie dzięki zmianom stylu życia Polaków (54% obserwowanej redukcji umieralności). 
Rozwój medycyny naprawczej także przyczynił się do redukcji liczby zgonów, choć w nieco mniejszym stopniu (37%). Dla-
tego bardzo istotna z punktu widzenia planowania polityki zdrowotnej państwa jest wiedza o rozpowszechnieniu zależnych 
od stylu życia czynników ryzyka CVD. Jeszcze ważniejsze są informacje o zmianach obciążenia populacji czynnikami ryzyka. 
Pozwoli to przewidywać przyszłe trendy umieralności, a także korzyści płynące z różnorodnych strategii populacyjnych w za-
kresie profilaktyki CVD. Ostatnie badanie przekrojowe dotyczące rozpowszechnienia czynników ryzyka CVD w populacji 
ogólnopolskiej przeprowadzono w latach 2005–2007, natomiast w 2011 r. zrealizowano badanie NATPOL 2011 będące 
najnowszym tego typu przedsięwzięciem w Polsce.
Cel: Celem badania NATPOL 2011 była ocena rozpowszechnienia wybranych czynników ryzyka CVD, w tym nadciśnienia 
tętniczego, zaburzeń lipidowych i cukrzycy w Polsce na podstawie badania reprezentatywnej próby mieszkańców oraz 
określenie aktualnych trendów w tym zakresie. Przedmiotem niniejszej publikacji jest natomiast szczegółowe określenie 
metodologii badania.
Metody: Projekt NATPOL 2011 zaplanowano jako badanie metodą reprezentacyjną. Grupę badaną stanowiła reprezentatyw-
na dla populacji ogólnopolskiej próba 2413 dorosłych osób (zakres wieku 18–79 lat). W celu uzyskania próby zastosowano 
losowanie warstwowe z uwagi na miejsce zamieszkania, wiek i płeć. Próba była skupiona w wiązkach terytorialnych. Dobór 
próby był etapowy: I etap — losowanie gmin, II etap — losowanie wiązek w obrębie gmin i losowanie indywidualnych 
respondentów (wykonane przez MSWiA z operatu PESEL). U każdego badanego, który wyraził na to zgodę, przeprowa-
dzono badanie kwestionariuszowe, pomiary ciśnienia tętniczego (3 pomiary podczas dwóch oddzielnych wizyt), pomiary 
antropometryczne. Pobrano także próbki krwi i moczu w celu wykonania oznaczeń biochemicznych [cholesterol całkowity 
w surowicy krwi; cholesterol frakcji LDL (wyliczony), HDL w surowicy krwi; triglicerydy na czczo w surowicy krwi; glukoza 
na czczo w osoczu krwi; sód i potas w surowicy krwi; kreatynina w surowicy krwi; insulina na czczo w surowicy krwi; białko 
C-reaktywne w surowicy krwi; aminotransferazy alaninowa i asparaginianowa w surowicy krwi; bilirubina w surowicy krwi; 
albumina w surowicy krwi; TSH, fT4 w surowicy krwi; albumina w moczu; kreatynina w moczu; sód i potas w moczu; NT-
-proBNP w osoczu]. Prace terenowe były realizowane przez specjalnie przeszkolone pielęgniarki zamieszkujące w pobliżu 
wylosowanych wiązek terytorialnych. Głównym realizatorem badania był zespół Kliniki Nadciśnienia Tętniczego i Diabetologii 
Uniwersyteckiego Centrum Klinicznego w Gdańsku. Badanie zrealizowano we współpracy z Warszawskim Uniwersytetem 
Medycznym i Instytutem Kardiologii w Warszawie.
Wyniki i wnioski: Listy zapraszające wysłano do 4420 potencjalnych uczestników badania. Spośród nich 786 osób było 
niedostępnych z powodu błędnego adresu, zmiany miejsca zamieszkania lub zgonu przed rozpoczęciem badania. Kolejne 
661 osób bądź odmówiło udziału w badaniu, bądź pielęgniarkom nie udało się z nimi nawiązać kontaktu. Ostatecznie w ba-
daniu wzięło udział 2413 osób, natomiast pełen zestaw badań, w tym próbki krwi i moczu, uzyskano w 2401 przypadkach, 
dlatego efektywność badania wyniosła 66,5%. Struktura próby zbadanej pod względem wieku i płci była niemal identyczna 
ze strukturą populacji polskiej z 2010 r. według GUS. Zakres nadanych wag wyniósł: 0,36–4,11.
Słowa kluczowe: choroby sercowo-naczyniowe, czynniki ryzyka, rozpowszechnienie
Kardiol Pol 2013; 71, 4: 381–392
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SUPPLEMENT 1. Tests performed in Central Clinical Laboratory — NATPOL 2011
Test
Methodology/reagents  
manufacturer
Analytical characteristics 
of the method applied
Analyser Bi
as
W
it
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-r
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n
 
im
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re
ci
si
o
n
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ee
n
-r
u
n
 
im
p
re
ci
si
o
n
1 Serum  
cholesterol 
Enzymatic/cholesterol esterase and cholesterol 
oxidase/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
–1.00% 0.60% 1.50%
2 Serum  
HDL-cholesterol 
Direct method — Accelerator Selective  
Detergent (ASD) with accelerated  
non-HDL-C oxidation and HDL-C dissolving/ 
/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
2.00% 1.10% 5.70%
3 LDL-cholesterol  
— calculated
Using Friedewald formula:
LDL-C [mg/dL] = total cholesterol [mg/dL] – HDL-C [mg/dL] – triglycerides [mg/dL]/5
If triglycerides concentration > 350 mg/dL, Friedewald formula cannot be used 
4 Serum triglycerides Enzymatic/glycerol kinase and glycerol  
phosphate oxidase/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
1.35% 1.43% 1.44%
5 Plasma glucose Enzymatic/hexokinase and glucose-6-phosphate 
dehydrogenase/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
–2.70% 1.30% 2.10%
6 Serum sodium Indirect ion-selective electrode/Abbott  
Laboratories
Architect c8000 Abbott 
Laboratories
–0.82% 0.35% 1.45%
7 Urine sodium Indirect ion-selective electrode/Abbott  
Laboratories
Architect c8000 Abbott 
Laboratories
2.36% 0.51% 1.46%
8 Serum potassium Indirect ion-selective electrode/Abbott  
Laboratories
Architect c8000 Abbott 
Laboratories
0.80% 0.30% 1.50%
9 Urine potassium Indirect ion-selective electrode/Abbott  
Laboratories
Architect c8000 Abbott 
Laboratories
0.80% 0.40% 1.30%
10 Serum creatinine Jaffe method: the reaction with picrate in  
alkaline milieu/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
1.10% 1.30% 3.10%
11 eGFR Calculated using the simplified MDRD equation: eGFR = 175× [(S × 0.0113)-1.154] × [age (years)]-0.203 × Z,  
where: S — serum creatinine [µmol/L]; Z = 0.742 (factor for females); Z = 1 (factor for males)
12 Urine creatinine Jaffe method: the reaction with picrate  
in alkaline milieu/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
5.40% 1.50% 2.50%
13 Serum insulin Immunochemiluminescence/Abbott Laboratories Architect I2000 Abbott 
Laboratories
2.30% 1.50% 3.30%
14 Serum CRP Immunoturbidimetry/Abbott Laboratories Architect c8000 Abbott 
Laboratories
8.90% 1.74% 2.55%
15 Serum total bilirubin Diazonium salt/Abbott Laboratories Architect c8000 Abbott 
Laboratories
–10.90% 2.70% 6.40%
16 Serum AST NADH without pyridoxal phosphate/ 
/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
–8.80% 0.90% 1.00%
17 Serum ALT NADH without pyridoxal phosphate/ 
/Abbott Laboratories
Architect c8000 Abbott 
Laboratories
–0.60% 1.40% 1.70%
18 Serum albumin Bromocresol purple/Abbott Laboratories Architect c8000 Abbott 
Laboratories
–0.60% 1.40% 1.75
19 Serum TSH Immunochemiluminescence/Abbott Laboratories Architect I2000 Abbott 
Laboratories
2.79% 2.01% 2.82%
20 Serum ft4 Immunochemiluminescence/Abbott Laboratories Architect I2000 Abbott 
Laboratories
–4.95% 6.04% 8.34%
21 Urine albumin Immunoturbidimetry/Abbott Laboratories Architect c8000 Abbott  
Laboratories
3.72% 4.45% 5.28%
22 Plasma NT-proBNP Immunochemiluminescence/Siemens  
Healthcare Diagnostics
Immulite 1000 Siemens 
Healthcare Diagnostics
–7.96% 0.15% 0.35%
23 Serum apoA1 Immunonephelometry/Siemens  
Healthcare Diagnostics
BN II Siemens  
Healthcare Diagnostics
5.13% 1.81% 7.97%
24 Serum apoB Immunonephelometry/Siemens  
Healthcare Diagnostics
BN II Siemens  
Healthcare Diagnostics
–4.66% 3.94% 9.38%
